Meet us at CPHI 2019 in Frankfurt! 13.06.2019

Meet us at CPHI 2019 in Frankfurt!

Alsachim is glad to be attending CPHI 2019 in Frankfurt and will be showcasing its products in the Fine Chemicals exhibition at booth 80971NEP! CPhI Worldwide is the world's largest [...]

[13C6] Brigatinib, new Tyrosine Kinase Inhibitors available now 31.05.2019

[13C6] Brigatinib, new Tyrosine Kinase Inhibitors available now

Alsachim has developed a new Tyrosine Kinase Inhibitors stable labeled standards, you can now get access to these standards to boost your research. Tyrosine Kinase inhibitors have always been [...]

5 Fluoro-uracil: Prevention of the toxicity 20.05.2019

5 Fluoro-uracil: Prevention of the toxicity

5 Fluoro-uracil toxicity has been proven and a pre-treatment assessment is now mandatory. Alsachim has developed the standards essential for the analysis. Uracil [13C,15N2] [...]

[13C6] Thiotepa: A new era for the anticancer research! 07.03.2019

[13C6] Thiotepa: A new era for the anticancer research!

A new and unique revelation has been uncovered by Alsachim. For the first time ever, the one of a kind stable labeled standard of Thiotepa, [13C6] Thiotepa, is available. This represents a big [...]

Alsachim Obtains ISO 13485 Quality Management Standard Certification for reagent 14.09.2018

Alsachim Obtains ISO 13485 Quality Management Standard Certification for reagent

Alsachim has obtained ISO 13485 certification for its in vitro diagnostic kits business, demonstrating the company's ability to meet regulatory requirements and its commitment to the quality of [...]

Shimadzu has acquired Alsachim 15.12.2017

Shimadzu has acquired Alsachim

Shimadzu, one of the world leaders in analytical instrumentation, has joined forces with the France-based Alsachim company, an independent contract research and development organization. [...]

Search on news

News archives